Search by Drug Name or NDC
NDC 43386-0771-03 Flucytosine 250 mg/1 Details
Flucytosine 250 mg/1
Flucytosine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals,Inc.. The primary component is FLUCYTOSINE.
Product Information
| NDC | 43386-0771 |
|---|---|
| Product ID | 43386-771_23a1fa95-2d66-4e32-8dc6-ebfdb0fcac56 |
| Associated GPIs | 11000020000105 |
| GCN Sequence Number | 009542 |
| GCN Sequence Number Description | flucytosine CAPSULE 250 MG ORAL |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 42560 |
| HICL Sequence Number | 004131 |
| HICL Sequence Number Description | FLUCYTOSINE |
| Brand/Generic | Generic |
| Proprietary Name | Flucytosine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Flucytosine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | FLUCYTOSINE |
| Labeler Name | Lupin Pharmaceuticals,Inc. |
| Pharmaceutical Class | Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204652 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43386-0771-03 (43386077103)
| NDC Package Code | 43386-771-03 |
|---|---|
| Billing NDC | 43386077103 |
| Package | 30 CAPSULE in 1 BOTTLE (43386-771-03) |
| Marketing Start Date | 2017-07-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |